Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.

Journal of palliative medicine - 1 Dec 2016

Bauman Jessica R, Piotrowska Zofia, Muzikansky Alona, Gallagher Emily, Scribner Emily, Temel Brandon, Sequist Lecia V, Heist Rebecca S, Temel Jennifer S

Abstract excerpt

BACKGROUND/OBJECTIVE: Patients with metastatic nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations benefit from improved survival and quality of life with EGFR-directed therapy. We sought to explore if these improvements in cancer care impacted the delivery of end-of-life (EOL) care in this population. DESIGN: We retrospectively reviewed medical records of patients cared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Share to Quality of Life

Source

Identifiers

PMID: 27626514
DOI: 10.1089/jpm.2016.0180

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.PMID 27626514Read ↗

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.Semantic proximity Read ↗

Costs of Cancer Care in the Last Five Days of Life in a Low-Resource SettingSemantic proximity Read ↗

Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors.Semantic proximity Read ↗

Optimal Timing for Hospice-shared Care in Terminal Cancer PatientsSemantic proximity Read ↗

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.Semantic proximity Read ↗

The Hospitalist-led Model of Oncology Inpatients in an Academic Health System: Perspectives of Hospitalists and Oncologists.Semantic proximity Read ↗

A Comprehensive Analysis of 5-Year Outcomes in Patients With Cancer Admitted to Intensive Care UnitsSemantic proximity Read ↗

Characteristics of patients who die in an acute palliative care unitSemantic proximity Read ↗

Analysis of Types And Costs of Drugs Used For 7 Days Before Death of Terminal Cancer Patients Hospitalized In Hospice And General Wards.Semantic proximity Read ↗

Cost consequences of unscheduled emergency admissions in cancer patients in the last year of lifeSemantic proximity Read ↗

The one-year outcomes of life-sustaining treatments in intensive care units among cancer patients at the end of life stage in Taiwan: A retrospective design.Semantic proximity Read ↗

Comparison of Survival Between Patients Receiving General Ambulatory Palliative Care and Patients Receiving Other Palliative Care - Analysis of Data of a Statutory Health Insurance DataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.